Extended Data Fig. 3: Correlations between a, Anti-SARS-CoV-2 spike and RBD IgG. b, Anti-SARS-CoV-2 Spike IgG and pseudovirus neutralisation titre. c, Anti-SARS-CoV-2 Spike IgG and live virus neutralisation titre. d, pseudovirus neutralisation titres and live virus neutralisation titres.
From: Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
95% confidence ellipses assuming a t-distribution are shown for each outcome (primary symptomatic cases, asymptomatic cases and negative controls). Pearson correlation coefficients shown as r values using all available data. Primary symptomatic cases: NAAT+ with at least one COVID symptom (cough, fever, shortness of breath, anosmia, aguesia). Asymptomatic cases: NAAT+ on weekly self-swab with no symptoms recorded.
